i
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
-
Jun 23 2017
-
-
Source: Res Pract Thromb Haemost. 1(1):33-40.
[PDF-676.45 KB]
Details:
-
Alternative Title:Res Pract Thromb Haemost
-
Personal Author:
-
Description:EssentialsMinor abundance plasma lipids, eg, glucosylceramide, can modulate blood coagulation reactionsThis lipid was measured in plasmas of 1 myocardial infarction and 2 venous thrombosis populationsLow plasma glucosylceramide levels were found in each population compared to matched controlsLow plasma glucosylceramide levels are associated with venous and arterial thrombosis
Background
One previous pilot study suggested the association of low plasma glucosylceramide (GlcCer) levels with venous thrombosis (VTE) risk.
Objective
We aimed to confirm and evaluate the association of low plasma GlcCer levels with VTE and myocardial infarction (MI) occurrence, respectively.
Patients and Methods
We evaluated the association of GlcCer in two independent case‐control studies of Caucasian VTE populations (N=210 and 636) and one case‐control study of Caucasian MI patients (N=345).
Result
Plasma GlcCer levels in VTE patients were lower compared to controls in two independent VTE populations (5.0 vs 5.8 μg/mL, P=.003 for the Scripps registry, and 5.6 vs 6.0 μg/mL, P=.001 for the Valencia registry, respectively). A low plasma GlcCer level (below tenth percentile of controls) was associated with increased VTE occurrence (odds ratio [OR]=3.7 [95% CI, 1.8‐7.9] for Scripps registry and OR=2.1 [95% CI, 1.3‐3.3] for Valencia registry, respectively). For the MI study, the median GlcCer plasma level was lower in MI patients than in controls (4.3 vs 5.6 μg/mL, P<.001), and a low level of GlcCer (below tenth percentile of control) was associated with higher MI occurrence (OR=7.7, [95% CI, 4.3‐13.8]).
Conclusion
Lower concentration of GlcCer was associated with VTE occurrence in 2 independent studies and also with MI occurrence in 1 study.
-
Subjects:
-
Source:
-
Pubmed ID:29202121
-
Pubmed Central ID:PMC5703432
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
